Tolero Pharmaceuticals, Inc. Email Format

Pharmaceutical ManufacturingUtah, United States2-10 Employees

Tolero Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Salt Lake City, Utah, focused on developing treatments for hematologic and oncologic diseases. The organization aims to improve and extend patients’ lives by addressing key biological drivers of blood disorders, including leukemias and anemia, as well as mechanisms of drug resistance and transcriptional control. Its work centers on translating insights into therapies that target these areas, with a pipeline built around complex hematologic and cancer-related pathways. In August 2018, Tolero entered into a clinical research collaboration with AbbVie to explore combination therapy involving AbbVie’s venetoclax and Tolero’s alvocidib for relapsed or refractory acute myeloid leukemia, representing a notable partnership in its early-stage development efforts.

Sign up for free to view info

Company overview Employee directory